gamma-fagarine has been researched along with medroxyprogesterone acetate in 1 studies
Studies (gamma-fagarine) | Trials (gamma-fagarine) | Recent Studies (post-2010) (gamma-fagarine) | Studies (medroxyprogesterone acetate) | Trials (medroxyprogesterone acetate) | Recent Studies (post-2010) (medroxyprogesterone acetate) |
---|---|---|---|---|---|
23 | 0 | 5 | 5,123 | 1,115 | 1,099 |
Protein | Taxonomy | gamma-fagarine (IC50) | medroxyprogesterone acetate (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 0.924 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.013 | |
Progesterone receptor | Homo sapiens (human) | 2.5081 | |
Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.019 | |
Mineralocorticoid receptor | Homo sapiens (human) | 1.197 | |
Androgen receptor | Homo sapiens (human) | 0.0061 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.279 | |
Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.019 | |
Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.019 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.197 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 1.4059 | |
Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 4.0405 | |
Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 1.8 | |
Estrogen receptor beta | Homo sapiens (human) | 0.924 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for gamma-fagarine and medroxyprogesterone acetate
Article | Year |
---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |